Abstract:Inositol trisphosphate receptor (IP3R)-mediated intracellular Ca2+ increase is the major Ca2+ signaling pathway in astrocytes in the central nervous system (CNS). Ca2+ increases in astrocytes have been found to modulate neuronal function through gliotransmitter release. We previously demonstrated that astrocytes exhibit enhanced Ca2+ signaling in vivo after photothrombosis (PT)-induced ischemia, which is largely due to the activation of G-protein coupled receptors (GPCRs). The aim of this study is to investigate the role of astrocytic IP3R-mediated Ca2+ signaling in neuronal death, brain damage and behavior outcomes after PT. For this purpose, we conducted experiments using homozygous type 2 IP3R (IP(3)R2) knockout (KO) mice. Histological and immunostaining studies showed that IP(3)R2 KO mice were indeed deficient in IP(3)R2 in astrocytes and exhibited normal brain cytoarchitecture. IP(3)R2 KO mice also had the same densities of S100 beta+ astrocytes and NeuN+ neurons in the cortices, and exhibited the same glial fibrillary acidic protein (GFAP) and glial glutamate transporter (GLT-1) levels in the cortices and hippocampi as compared with wild type (WT) mice. Two-photon (2-P) imaging showed that IP(3)R2 KO mice did not exhibit ATP-induced Ca2+ waves in vivo in the astrocytic network, which verified the disruption of IP3R-mediated Ca2+ signaling in astrocytes of these mice. When subject to PT, IP(3)R2 KO mice had smaller infarction than WT mice in acute and chronic phases of ischemia. IP(3)R2 KO mice also exhibited less neuronal apoptosis, reactive astrogliosis, and tissue loss than WT mice. Behavioral tests, including cylinder, hanging wire, pole and adhesive tests, showed that IP(3)R2 KO mice exhibited reduced functional deficits after PT. Collectively, our study demonstrates that disruption of astrocytic Ca2+ signaling by deleting IP(3)R2s has beneficial effects on neuronal and brain protection and functional deficits after stroke. These findings reveal a novel non-cell-autonomous neuronal and brain protective function of astrocytes in ischemic stroke, whereby suggest that the astrocytic IP(3)R2-mediated Ca2+ signaling pathway might be a promising target for stroke therapy. (C) 2015 Elsevier Ltd. All rights reserved.

Abstract WMP38: Inhibition of Rip1 Kinase Improves Brain Functional Recovery after Ischemic Stroke Via Reducing Astrocytic Scar Formation

Inhibition of Receptor-Interacting Protein 3 Upregulation and Nuclear Translocation Involved in Necrostatin-1 Protection Against Hippocampal Neuronal Programmed Necrosis Induced by Ischemia/reperfusion Injury.

The Key Regulator of Necroptosis, RIP1 Kinase, Contributes to the Formation of Astrogliosis and Glial Scar in Ischemic Stroke

Inhibition of GSK3β and RIP1K Attenuates Glial Scar Formation Induced by Ischemic Stroke via Reduction of Inflammatory Cytokine Production

Inhibition of GSK3 and RIP1K Attenuates Glial Scar Formation Induced by Ischemic Stroke<i>via</i> Reduction of Inflammatory Cytokine Production

RIP3 induces ischemic neuronal DNA degradation and programmed necrosis in rat via AIF

Inhibiting of RIPK3 Attenuates Early Brain Injury Following Subarachnoid Hemorrhage: Possibly Through Alleviating Necroptosis

Disruption Of Ip(3)R2-Mediated Ca2+ Signaling Pathway In Astrocytes Ameliorates Neuronal Death And Brain Damage While Reducing Behavioral Deficits After Focal Ischemic Stroke

RIP1K Contributes to Neuronal and Astrocytic Cell Death in Ischemic Stroke Via Activating Autophagic-lysosomal Pathway.

RIPK1 inhibition contributes to lysosomal membrane stabilization in ischemic astrocytes via a lysosomal Hsp70.1B-dependent mechanism

Limb remote ischemic post-conditioning mitigates brain recovery in a mouse model of ischemic stroke by regulating reactive astrocytic plasticity.

Downregulation of Ripk1 and Nsf mediated by CRISPR-CasRx ameliorates stroke volume and neurological deficits after ischemia stroke in mice

The Neuroprotective Effects of Necrostatin-1 on Subarachnoid Hemorrhage in Rats are Possibly Mediated by Preventing Blood-Brain Barrier Disruption and RIP3-Mediated Necroptosis.

Inhibiting RIPK1-driven neuroinflammation and neuronal apoptosis mitigates brain injury following experimental subarachnoid hemorrhage

Effect Of Remote Ischemic Postconditioning On An Intracerebral Hemorrhage Stroke Model In Rats

Specific necroptosis inhibitor-1( Nec-1) attenuates glial scar formation in rat models with spinal cord injury

Necrostatin-1 Prevents Necroptosis in Brains after Ischemic Stroke Via Inhibition of RIPK1-Mediated RIPK3/MLKL Signaling

Catalytically inactive RIP1 and RIP3 deficiency protect against acute ischemic stroke by inhibiting necroptosis and neuroinflammation

AKT/GSK3β-Dependent Autophagy Contributes to the Neuroprotection of Limb Remote Ischemic Postconditioning in the Transient Cerebral Ischemic Rat Model.

Abstract TP259: Neuroprotective Effects Of Ripk2 Deficiency In Experimental Ischemic Stroke

Genetic inhibition of RIPK3 ameliorates functional outcome in controlled cortical impact independent of necroptosis